Literature DB >> 33946290

Catalase Protects Biofilm of Staphylococcus aureus against Daptomycin Activity.

Cristina El Haj1, Mads Lichtenberg1, Karen Leth Nielsen2, Thomas Bjarnsholt1,2, Peter Østrup Jensen1,2,3.   

Abstract

Daptomycin is recommended for the treatment of Staphylococcus aureus infections due to its bactericidal activity. However, its mechanism of action is poorly understood. The involvement of reactive oxygen species (ROS) in the bactericidal activity of daptomycin has been proved against planktonic S. aureus, but not against the biofilm of S. aureus. Therefore, we evaluated if ROS contributes to the effect of daptomycin against biofilm of S. aureus. Biofilms of wild type, catalase deficient and daptomycin-resistant S. aureus strains were grown in microtiter-plates. After three days, the biofilms were exposed to daptomycin with or without thiourea in the presence of a ROS indicator. After overnight incubation, the amount of ROS and the percentage of surviving bacteria were determined. The bacterial survival was higher and the amount of ROS was lower in the wild type than in the catalase deficient biofilm, demonstrating a protective effect of catalase against daptomycin. The induction of cytotoxic ROS formation by daptomycin was verified by the addition of thiourea, which reduced the amount of ROS and protected the wild type biofilm against high concentrations of daptomycin. Accordingly, only the highest concentration of daptomycin reduced the bacterial survival and increased the ROS formation in the resistant biofilm. In conclusion, daptomycin induced the production of cytotoxic levels of endogenous ROS in S. aureus biofilm and the presence of catalase protected the biofilm against the lethality of the induced ROS.

Entities:  

Keywords:  Staphylococcus aureus; biofilm; catalase; daptomycin

Year:  2021        PMID: 33946290     DOI: 10.3390/antibiotics10050511

Source DB:  PubMed          Journal:  Antibiotics (Basel)        ISSN: 2079-6382


  27 in total

Review 1.  Antibiotic resistance of bacteria in biofilms.

Authors:  P S Stewart; J W Costerton
Journal:  Lancet       Date:  2001-07-14       Impact factor: 79.321

Review 2.  Mechanisms of drug resistance: daptomycin resistance.

Authors:  Truc T Tran; Jose M Munita; Cesar A Arias
Journal:  Ann N Y Acad Sci       Date:  2015-10-23       Impact factor: 5.691

3.  Catalase (KatA) and alkyl hydroperoxide reductase (AhpC) have compensatory roles in peroxide stress resistance and are required for survival, persistence, and nasal colonization in Staphylococcus aureus.

Authors:  Kate Cosgrove; Graham Coutts; Ing-Marie Jonsson; Andrej Tarkowski; John F Kokai-Kun; James J Mond; Simon J Foster
Journal:  J Bacteriol       Date:  2006-11-17       Impact factor: 3.490

4.  Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.

Authors:  Vance G Fowler; Helen W Boucher; G Ralph Corey; Elias Abrutyn; Adolf W Karchmer; Mark E Rupp; Donald P Levine; Henry F Chambers; Francis P Tally; Gloria A Vigliani; Christopher H Cabell; Arthur Stanley Link; Ignace DeMeyer; Scott G Filler; Marcus Zervos; Paul Cook; Jeffrey Parsonnet; Jack M Bernstein; Connie Savor Price; Graeme N Forrest; Gerd Fätkenheuer; Marcelo Gareca; Susan J Rehm; Hans Reinhardt Brodt; Alan Tice; Sara E Cosgrove
Journal:  N Engl J Med       Date:  2006-08-17       Impact factor: 91.245

Review 5.  The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria.

Authors:  M J Rybak
Journal:  Clin Microbiol Infect       Date:  2006-03       Impact factor: 8.067

Review 6.  Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections.

Authors:  Judith N Steenbergen; Jeff Alder; Grace M Thorne; Francis P Tally
Journal:  J Antimicrob Chemother       Date:  2005-02-10       Impact factor: 5.790

7.  A common mechanism of cellular death induced by bactericidal antibiotics.

Authors:  Michael A Kohanski; Daniel J Dwyer; Boris Hayete; Carolyn A Lawrence; James J Collins
Journal:  Cell       Date:  2007-09-07       Impact factor: 41.582

8.  Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells.

Authors:  Carmela T M Mascio; Jeff D Alder; Jared A Silverman
Journal:  Antimicrob Agents Chemother       Date:  2007-10-08       Impact factor: 5.191

Review 9.  Daptomycin.

Authors:  Mohsen Heidary; Azar Dohkt Khosravi; Saeed Khoshnood; Mohammad Javad Nasiri; Saleh Soleimani; Mehdi Goudarzi
Journal:  J Antimicrob Chemother       Date:  2018-01-01       Impact factor: 5.790

10.  Staphylococcus aureus adapts to oxidative stress by producing H2O2-resistant small-colony variants via the SOS response.

Authors:  Kimberley L Painter; Elizabeth Strange; Julian Parkhill; Kathleen B Bamford; Darius Armstrong-James; Andrew M Edwards
Journal:  Infect Immun       Date:  2015-02-17       Impact factor: 3.441

View more
  2 in total

Review 1.  The structure-function relationship of Pseudomonas aeruginosa in infections and its influence on the microenvironment.

Authors:  Mads Lichtenberg; Tim Holm Jakobsen; Michael Kühl; Mette Kolpen; Peter Østrup Jensen; Thomas Bjarnsholt
Journal:  FEMS Microbiol Rev       Date:  2022-09-02       Impact factor: 15.177

Review 2.  Potential Advances of Adjunctive Hyperbaric Oxygen Therapy in Infective Endocarditis.

Authors:  Christian Johann Lerche; Franziska Schwartz; Mia Marie Pries-Heje; Emil Loldrup Fosbøl; Kasper Iversen; Peter Østrup Jensen; Niels Høiby; Ole Hyldegaard; Henning Bundgaard; Claus Moser
Journal:  Front Cell Infect Microbiol       Date:  2022-02-03       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.